SSShreyada N. Save

Shreyada N. Save

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shreyada N. Save has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pyrrole‐Linked Benzimidazolyl Hydrazone Self‐Assembly Forms HCl Channels and Induces Apoptosis in Cancer Cells

    by Abhishek Mondal, Shreyada N. Save, Susmita Sarkar, Abhijith Kuttanamkuzhi, Sumit Bawari, Thangavel Vijayakanth, Umesh Shivpuje, Mayurika Lahiri, Jagannath Mondal, Shilpy Sharma, et al.

    Modulation of intracellular chloride ion concentration by artificially developed ion transporters has been known to induce apoptosis in cancer cells. However, most of these transporters cause harm to healthy cells as well, limiting their applicability in real biological systems. Here, we report a pyrrole‐linked benzimidazolyl‐hydrazone that self‐assembles to form a nanochannel assembly across the lipid bilayer, enabling the selective translocation of HCl, a system rarely reported in the literature. The channel shows an extraordinarily high HCl transport activity with an EC50 value as low as 0.016 mol%, relative to lipid. We demonstrate solid‐state evidence that compound 1 self‐assembles in the presence of HCl to produce organized arrays that include chloride‐filled and water‐filled channels. The formation of a stable HCl channel across the lipid bilayer membrane was verified through electrophysiological experiments, detailed molecular dynamics (MD) simulations, and quantum mechanical calculations. When tested in cellular systems, the compound showed pronounced toxicity toward cancerous cell lines while remaining relatively nontoxic to cell lines of non‐cancerous origin. Interestingly, compound 1 was also found to inhibit the growth and proliferation of MCF‐7‐derived 3D spheroids with higher efficiency when compared to the commercially available anticancer drug─doxorubicin (DOX).


  • Pyrrole‐Linked Benzimidazolyl Hydrazone Self‐Assembly Forms HCl Channels and Induces Apoptosis in Cancer Cells

    by Abhishek Mondal, Shreyada N. Save, Susmita Sarkar, Abhijith Kuttanamkuzhi, Sumit Bawari, Thangavel Vijayakanth, Umesh Shivpuje, Mayurika Lahiri, Jagannath Mondal, Shilpy Sharma, et al.

    Modulation of intracellular chloride ion concentration by artificially developed ion transporters has been known to induce apoptosis in cancer cells. However, most of these transporters cause harm to healthy cells as well, limiting their applicability in real biological systems. Here, we report a pyrrole‐linked benzimidazolyl‐hydrazone that self‐assembles to form a nanochannel assembly across the lipid bilayer, enabling the selective translocation of HCl, a system rarely reported in the literature. The channel shows an extraordinarily high HCl transport activity with an EC50 value as low as 0.016 mol%, relative to lipid. We demonstrate solid‐state evidence that compound 1 self‐assembles in the presence of HCl to produce organized arrays that include chloride‐filled and water‐filled channels. The formation of a stable HCl channel across the lipid bilayer membrane was verified through electrophysiological experiments, detailed molecular dynamics (MD) simulations, and quantum mechanical calculations. When tested in cellular systems, the compound showed pronounced toxicity toward cancerous cell lines while remaining relatively nontoxic to cell lines of non‐cancerous origin. Interestingly, compound 1 was also found to inhibit the growth and proliferation of MCF‐7‐derived 3D spheroids with higher efficiency when compared to the commercially available anticancer drug─doxorubicin (DOX).


  • Open Access

    Bisindole-based small molecules as transmembrane anion transporters and potential anticancer agents

    by Swati Bansi Salunke, Shreyada N. Save, Naveen J. Roy, Ronedy Naorem, Shilpy Sharma, Pinaki Talukdar

    Few synthetic ion transporters have been reported incorporating indole as the core moiety. We have developed a novel bisindole-based transporter capable of efficient transmembrane anion antiport. This system induced cytotoxicity in MCF-7 breast cancer cells via chloride ion homeostasis disruption and the associated ROS generation, mitochondrial membrane depolarization, and lysosomal deacidification.


  • NAD(P)H:Quinone Acceptor Oxidoreductase 1 (NQO1) Activatable Salicylamide H+/Cl− Transporters

    by Naveen J. Roy, Shreyada N. Save, Virender Kumar Sharma, Benchamin Abraham, Abhijith Kuttanamkuzhi, Shilpy Sharma, Mayurika Lahiri, Pinaki Talukdar

    NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a detoxifying enzyme overexpressed in tumors, plays a key role in protecting cancer cells against oxidative stress and thus has been considered an attractive candidate for activating prodrug(s). Herein, we report the first use of NQO1 for the selective activation of ‘protransporter’ systems in cancer cells leading to the induction of apoptosis. Salicylamides, easily synthesizable small molecules, have been effectively used for efficient H+/Cl− symport across lipid membranes. The ion transport activity of salicylamides was efficiently abated by caging the OH group with NQO1 activatable quinones via either ether or ester linkage. The release of active transporters, following the reduction of quinone caged ‘protransporters’ by NQO1, was verified. Both the transporters and protransporters exhibited significant toxicity towards the MCF‐7 breast cancer line, mediated via the induction of oxidative stress, mitochondrial membrane depolarization, and lysosomal deacidification. Induction of cell death via intrinsic apoptotic pathway was verified by monitoring PARP1 cleavage.